Domain Biotech: plans to raise funds not exceeding 465 million yuan through targeted issuance.

Announcement from Tianyu Biotechnology: The company plans to issue shares to specific investors to raise funds not exceeding 465 million yuan. The funds raised will be used to supplement working capital and repay debts after deducting issuance expenses. The number of shares to be issued this time will not exceed 71.0283 million shares, and the recipients of the shares will be Daoyun Assets controlled by the actual controller of the company, Luo Weiguo.